GFM
ZYME icon

GF Fund Management’s Zymeworks ZYME Stock Holding History

GF Fund Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.4K Sell
1,585
-96
-6% -$2.44K ﹤0.01% 410
2026
Q1 		$42.1K Buy
1,681
+211
+14% +$4.99K ﹤0.01% 417
2025
Q4 		$38.7K Sell
1,470
-147
-9% -$3.21K ﹤0.01% 427
2025
Q3 		$27.6K Sell
1,617
-146
-8% -$2.09K ﹤0.01% 451
2025
Q2 		$22.1K Hold
1,763
– – ﹤0.01% 492
2025
Q1 		$21K Buy
1,763
+317
+22% +$4.32K ﹤0.01% 498
2024
Q4 		$21.2K Buy
+1,446
New +$20.2K ﹤0.01% 467

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

GF Fund Management's ZYME Position: Q2 2026 in Review

GF Fund Management reduced its Zymeworks (ZYME) stake by 5.7% in Q2 2026, selling an estimated $2.44K and leaving 1,585 shares worth $41.4K. The position accounts for ﹤0.01% of the portfolio, ranked #410.

GF Fund Management first reported a position in ZYME in Q4 2024 and has held it in 7 quarters since. The position peaked at $42.1K in Q1 2026. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • GF Fund Management held 1,585 shares of Zymeworks worth $41.4K as of Q2 2026.
  • GF Fund Management sold 96 Zymeworks shares in Q2 2026, an estimated $2.44K.
  • Zymeworks made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #410 holding.
  • GF Fund Management first reported a position in Zymeworks in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Zymeworks position peaked at $42.1K in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.